GW Pharmaceuticals Plc Performance
The company owns a Beta (Systematic Risk) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and GW Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days GW Pharmaceuticals Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, GW Pharmaceuticals is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Quick Ratio | 3.49 | |
| Fifty Two Week Low | 87.07 | |
| Target High Price | 220.00 | |
| Fifty Two Week High | 219.54 | |
| Target Low Price | 125.00 |
GWPH |
GW Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in GW Pharmaceuticals Plc on January 19, 2024 and sell it today you would earn a total of 100.00 from holding GW Pharmaceuticals Plc or generate -100.0% return on investment over 90 days. GW Pharmaceuticals Plc is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than GWPH, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
GW Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GW Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GW Pharmaceuticals Plc, and traders can use it to determine the average amount a GW Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GWPH |
Based on monthly moving average GW Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GW Pharmaceuticals by adding GW Pharmaceuticals to a well-diversified portfolio.
GW Pharmaceuticals Fundamentals Growth
GWPH Stock prices reflect investors' perceptions of the future prospects and financial health of GW Pharmaceuticals, and GW Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GWPH Stock performance.
| Return On Equity | -7.92 | |||
| Return On Asset | -3.55 | |||
| Profit Margin | (11.03) % | |||
| Operating Margin | (9.82) % | |||
| Current Valuation | 6.42 B | |||
| Shares Outstanding | 31.54 M | |||
| Price To Earning | 126.70 X | |||
| Price To Book | 9.24 X | |||
| Price To Sales | 12.92 X | |||
| Revenue | 527.2 M | |||
| EBITDA | (39.01 M) | |||
| Cash And Equivalents | 486.75 M | |||
| Cash Per Share | 15.53 X | |||
| Total Debt | 43.64 M | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | 23.70 X | |||
| Cash Flow From Operations | (27.39 M) | |||
| Earnings Per Share | (1.86) X | |||
| Total Asset | 453.18 M | |||
| Retained Earnings | (813.7 M) | |||
| Current Asset | 404.52 M | |||
| Current Liabilities | 34.95 M | |||
Things to note about GW Pharmaceuticals Plc performance evaluation
Checking the ongoing alerts about GW Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GW Pharmaceuticals Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GW Pharmaceuticals is not yet fully synchronised with the market data | |
| GW Pharmaceuticals has some characteristics of a very speculative penny stock | |
| GW Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 527.2 M. Net Loss for the year was (58.13 M) with profit before overhead, payroll, taxes, and interest of 489.67 M. | |
| GW Pharmaceuticals Plc currently holds about 486.75 M in cash with (27.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.53. | |
| Over 80.0% of the company shares are owned by institutional investors |
- Analyzing GW Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GW Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining GW Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GW Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of GW Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GW Pharmaceuticals' stock. These opinions can provide insight into GW Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in GWPH Stock
If you are still planning to invest in GW Pharmaceuticals Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GW Pharmaceuticals' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |